Predicting cancer drivers: are we there yet?

5Citations
Citations of this article
30Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Genomic variants with a key role in causing cancer or affecting the response to cancertherapeutics need to be identified so that they can be targeted for therapy. The transFIC tool aimsto identify somatic point mutations that drive cancer in sequencing projects. This package isavailable as a web service, a stand-alone program and a website. It improves the functionalprediction scores generated by popular established prediction tools and will be useful to cancerresearchers.See research article: http://genomemedicine.com/content/4/11/89. © 2012 BioMed Central Ltd.

Cite

CITATION STYLE

APA

Krishnan, V. G., & Ng, P. C. (2012, November 26). Predicting cancer drivers: are we there yet? Genome Medicine. https://doi.org/10.1186/gm389

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free